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Abstract
Nanoporous poly(2-hydroxyethyl methacrylate-co-ethylene dimethacrylate) (HEMA-EDMA) is used as a 3D mesh for spotting
lipid arrays. Its porous structure is an ideal matrix for lipid ink to infiltrate, resulting in higher fluorescent signal intensity as com-
pared to similar arrays on strictly 2D substrates like glass. The embedded lipid arrays show high stability against washing steps,
while still being accessible for protein and antibody binding. To characterize binding to polymer-embedded lipids we have applied
Streptavidin as well as biologically important biotinylated androgen receptor binding onto 1,2-dipalmitoyl-sn-glycero-3-phospho-
ethanolamine-N-(cap biotinyl) (Biotinyl Cap PE) and anti-DNP IgE recognition of 2,4-dinitrophenyl[1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]hexanoyl] (DNP)] antigen. This approach adds lipid arrays to the range of
HEMA polymer applications and makes this solid substrate a very attractive platform for a variety of bio-applications.
Introduction
Starting with the creation of high density peptide microarrays in
the 1990s [1] the development of arrays with DNA molecules
and antibodies has produced a range of platforms for functional
determination studies of molecules [2-4]. Nowadays, commer-
cially available micro- and nanoarrays in a variety of design are
readily available. Lipid arrays, however, are a comparably
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novel platform and still not as well-developed. Studies using
lipid micro-/nanoarrays are often hampered due to the lack of
widely available technologies for lipid deposition [5] and the
detection of lipid–protein interactions [6]. Increased biological
importance of lipid arrays, demonstrated by the growing num-
ber of studies on autoimmune diseases such as multiple scle-
rosis [7,8], emphasizes the need for sustained progress in this
field.
The work presented here demonstrates the potential of
nanoporous poly(2-hydroxyethyl methacrylate-co-ethylene
dimethacrylate) (HEMA-EDMA) as a novel advantageous sub-
strate for lipid arrays. Porous HEMA support, with pore size
distribution in the range of 150 nm , has already demonstrated
advantages in pattern definition, spot homogeneity, and consis-
tent spot dimensions for different dye sensors (phloxine B and
bromophenol blue) spotted in ethanol based inks [9]. In the
present approach, the pores of the HEMA-EDMA support act as
a mesh that contains lipid ink in a confined space, providing
high pattern definition, and presenting more binding sites than
would be available on a flat substrate [10]. The main phospho-
lipid component in our ink mixture is 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC, Tm = −16.5 °C) which allowed for the
control of ink fluidity under humidity controlled conditions
[11,12]. Using quill-like pens (SPTs, short for surface pattern-
ing tool [13]) for lipid ink deposition permitted the reduction of
the volume of phospholipids needed for array generation, as
compared to other spotting techniques like ink jet printing,
without decrease in the quality of the array or reduction of
binding sites for analyte molecules. On the contrary, higher
resolutions and smaller feature sizes are obtained with the SPTs
in comparison with common ink jet procedures. We previously
demonstrated the use of SPTs for the deposition of water-based
click-chemistry inks [10,14,15] where CuAAC mediated cova-
lent immobilization of ink molecules and embedment’s within
the polymer mesh makes the pattern highly stable in solution
[10]. To determine if lipids deposited on nanoporous HEMA-
EDMA polymer could be used to generate functional arrays we
selected lipid–protein pairs applied in previous settings: Biotin-
Cap-PE and streptavidin labeled with Cy3 dye (STV-Cy3) as a
simple protein model; and DNP-cap-PE with anti-DNP IgE as a
model for allergen/antibody recognition. These interactions are
well-characterized for biomimetic lipid membranes on flat
supports [16,17] and there, interactions occur without any
special requirements, like pretreatment with co-activating mole-
cules. For a more complex protein, the lipid/HEMA-EDMA
substrate system was also characterized for the binding proper-
ties of biotinylated androgen receptor (ARbiot) [18] onto Biotin-
cap-PE arrays in the presence of a hormone. We have chosen
AR as a test protein because of its biological importance: the
transcriptional activity of this steroid receptor is crucial not only
for the normal development of the prostate in males, but it is
also vital in the progression of prostate cancer [19]. AR contrib-
utes to breast cancer progression and development [20] and its
mutation is involved in the progression of neurodegenerative
diseases, such as the X-linked spinal and bulbar muscular
atrophy [21]. In order to better understand and characterize the
behavior and mechanism of action of this receptor new ap-
proaches are needed to facilitate studies with AR. Embedding
AR in a lipid layer within HEMA-EDMA mesh might facilitate
studies relying not only on fluorescence microscopy techniques
but also on spectroscopy, to evaluate coactivators, co-chaper-
ones [22] and even novel antiandrogens affinity to the receptor
[6] and effects on the receptor’s poly Q-extended mutations
[23].
Results and Discussion
Microchannel cantilever spotting (µCS) with
phospholipids
In order to establish best conditions for microchannel cantile-
ver spotting (µCS) of phospholipids with the SPTs, we used
simple phospholipid ink composed of DOPC [1,2-dioleoyl-sn-
glycero-3-phosphocholine] doped with Rhodamine-PE [1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine
rhodamine B sulfonyl) (ammonium salt)]. The ink was pre-
pared by mixing DOPC and Rhodamine-PE to achieve 1 µM
lipid content in chloroform with 1 mol % fluorescent dye
admixture. The chloroform was evaporated and lipids were
reconstituted with an ethanol and glycerol mixture in 7:3 v/v
ratio. The ink was loaded onto a freshly oxygen plasma acti-
vated SPT and directly used for spotting. When varying the
contact time between SPT and substrate (dwell time), different
feature sizes can be obtained (Figure 1). The diameter of the
spotted features varies from 6 +/− 0.3 µm to 4 +/− 0.2 µm for
dwell times from 3 to 0.1 s. Interestingly, not only feature size,
but also fluorescence intensity varies with dwell time
(Figure 1b). This can be explained by the 3D nature of the fea-
tures as they are actually embedded in the porous HEMA-
EDMA substrate [10]. While on a flat glass substrate, features
can only grow into 2D with dwell time, while in the present
case features will also grow into the depth of the HEMA-
EDMA film, resulting in brighter fluorescence as the ink below
the feature surface also contributes to the signal.
Protein and antibody binding onto lipid arrays
The selective binding of proteins to the lipid arrays on HEMA
polymer was first tested using fluorophore labelled streptavidin
(STV-FITC) for the coupling with biotin headgroups. Biotin
lipid arrays were prepared by admixing 4 mol % biotin lipid
(1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap
biotinyl)) into the DOPC carrier. It was shown previously [24],
that this percentage admixture of biotin saturates the number of
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Figure 1: Phospholipid array on nanoporous HEMA-EDMA polymer. a) Phospholipid microcontact spotting on porous HEMA-EDMA with microchan-
nel cantilevers imaged in situ on the lithography system. b) Fluorescence microscopy image of the DOPC phospholipid array doped with Rhodamine-
PE (dwell times 3 to 0.1 s). The arrow indicates the intensity profile of dot features presented on the superimposed graph. Scale bar equals 50 µm.
c) Relationship between spot radius and dwell time for the microarray shown in (b).
Figure 2: a) Fluorescence image of the STV-FITC binding Biotin-PE containing arrays on the nanoporous HEMA-EDMA substrate. DOPC doped with
Rhodamine PE (red) was patterned around biotin array for optical reference with dwell time set to 1 s. Spotting dwell time for Biotin-PE containing
arrays was set to 2 s. Scale bar equals 50 µm. b) The graph shows the fluorescence intensity after background subtraction of dots indicated by an
arrow.
available biotin headgroups for protein binding [24]. After spot-
ting, the arrays were blocked with 10% bovine serum albumin
(BSA) to reduce unspecific binding of the protein to the
polymer. Next, samples were washed and incubated for 1 h with
0.5 µg solution of STV-FITC in phosphate buffered saline
(PBS). The observed STV-FITC fluorescence is homogenous
over the whole arrays, indicating an even distribution of biotin
headgroups embedded in the nanoporous HEMA-EDMA
(Figure 2).
To assess the accessibility of lipid based allergen arrays on
nanoporous HEM-EDMA A substrates to antibodies, we em-
ployed the established lipid/antibody pair DNP-cap-PE and
anti-DNP IgE antibody. Previously, DNP-lipid recognition by a
specific antibody was tested on glass supports [17], while on
HEMA-EDMA polymer antibody binding was tested on cova-
lently bound DNP-azide ink [10]. Here, allergen arrays were
prepared by using 10 mol % admixture of DNP-cap-PE into
DOPC lipid. As an optical reference DOPC doped with
rhodamine was patterned in-between DNP-lipid structures
(Figure 3a). After blocking with 10% BSA and subsequent
washing, samples were incubated with anti-DNP IgE antibody
labelled with Alexa 488 dye for direct visualization. Plotting of
the mean fluorescence intensity against dwell time (Figure 3b)
indicates a slight dependence of fluorescence intensity on dwell
time (suggesting the infiltrated nature of the features as ex-
plained above). Though the difference between 2 s, 1 s and 0.5 s
dwell time is not as strongly pronounced as in the case of the
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Figure 3: a) Fluorescence microscopy image of an anti-DNP IgE-Alexa 488 antibody (green) bound to an array of DNP-lipids on nanoporous HEMA-
EDMA substrate. DOPC doped with Rhodamine-PE was patterned on the same sample as optical reference (red) with dwell time set to 1 s. Scale bar
equals 50 µm. b) Fluorescence intensity of n = 5 dots features per dwell time of DNP-array (after background subtraction) presented in a) after binding
the anti-DNP IgE-Alexa 488 antibody.
DOPC ink (Figure 1b), this dependency overall suggests that
the antibody can access binding sites within the HEMA-EDMA
substrate.
To test the binding of a more complex, functional protein on the
HEMA-EDMA based lipid arrays, we chose ARbiot. Binding of
ARbiot to the HEMA-EDMA membrane was performed in the
presence of dihydrotestosterone hormone (DHT). The hormone
addition is needed to assure receptor stability as the AR is
known to be very unstable as an aporeceptor [25]. Firstly, biotin
carrying arrays for ARbiot binding were prepared as described in
the previous section with an admixing of 4 mol % biotin lipid
into DOPC carrier. Next, after blocking with 10% BSA and
binding of fluorescently labeled STV-Cy3, arrays were washed
with PBS and blocked again with 10% BSA to prepare mem-
branes for ARbiot binding. The coating of arrays with labeled
STV allowed for direct visualization of the biotin arrays. In the
last washing step after blocking with BSA dihydrotestosterone
(DHT, 10−4 M) was added to the buffer in order to prepare the
array for the binding of ARbiot onto the STV-Cy3–biotin arrays
[25]. Next, freshly purified ARbiot was loaded onto the sample
surface. After overnight incubation at 4 °C, arrays were washed
with PBS containing 10−4 DHT to maintain the AR stability.
Binding of ARbiot was detected via indirect immunofluores-
cence. First samples were blocked with fetal calf serum (FCS)
for 1 h at room temperature (RT), then washed with PBS con-
taining 10−4 DHT and loaded for 1 h with anti-AR antibody.
After another washing step, the sample was incubated with a
secondary antibody labeled with FITC, for 15 min, washed with
PBS containing 10−4 DHT and imaged with fluorescence
microscope. Figure 4 shows biotin arrays after binding of STV-
Cy3 (Texas Red channel) and ARbiot, detected with indirect
immunofluorescence (FITC channel). Binding of STV-Cy3
served as an optical reference to easily localize the lipid arrays
on the sample. Fluorescence signal after antibody binding on
ARbiot coated arrays is homogenous, indicating an even distri-
bution of the receptor bound to STV-biotin arrays embedded in
the HEMA-EDMA (Figure 4, graph).
Conclusion
We present a novel platform for binding studies of functional
molecules based on lipid arrays embedded in a nanoporous
hydrophilic polymer substrate. The microcontact spotting ap-
proach used to pattern the functional lipid inks into arrays
allows for the multiplexing of different inks into single arrays
within the polymer mesh. Spotting with SPT probes on HEMA-
EDMA polymer increases the spatial resolution of lipid pattern
as compared to conventional spotting/ink jet printing on 3D
substrates, such as PVDF or nitrocellulose membranes, from
50–300 µm in current commercial setups [26,27] to the
presented average 6 µm features by µCS. The 3D nature of the
spotted features (enabled by the infiltration of the ink into the
nanoporous polymer) results in a higher signal intensity com-
pared to similar arrays on strictly 2D substrates as glass [9,10].
As of now it is still unknown, just like in case of lipids spotted
on PVDF membranes [7], how the polymer mesh accommo-
dates lipid geometry and packaging, and how it affects the
accessibility of the target lipid regions for the binding of pro-
teins and antibodies. However, the infiltrated lipid arrays show
high stability against washing steps, while still being accessible
for protein and antibody binding. Even complex receptor pro-
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Figure 4: Fluorescence microscopy images of ARbiot binding onto STV-Cy3 coated biotin arrays on nanoporous HEMA-EDMA substrate. The STV-
Cy3 was pre-bound onto biotin lipid spots (red), ARbiot was detected by immunostaining (green). Scale bars equal 50 µm. All arrays were spotted with
a dwell time of 2 s. The graph presents intensity profiles of n = 9 dot features of two arrays, after STV-Cy3 (red points) and ARbiot binding (green
points) (after background subtraction).
tein structures of ARbiot remain intact upon binding to the lipid
arrays and are still accessible for the indirect immunofluores-
cence detection. The described model system and its demon-
strated feasibility exhibit a high potential for follow-up studies.
Even though the model is still very simplified, its ability to
reduce the complexity of interactions for the study of specific
aspects of AR function in protein complexes has been demon-
strated. This setup may allow for the investigation of differ-
ences between various protein complexes isolated from patho-
logical samples from mice models and patient samples. Anti-
body based detection approaches could be suitable to analyze
the levels of AR proteins bound onto the lipid arrays. The de-
scribed model system would thereby have a significant impact
on the therapeutic treatment for breast and prostate cancer
patients.
Keeping in mind previous applications of HEMA polymer in
creating superhydrophilic–superhydrophobic micropatterned
surfaces for cell patterning [28] and cell-screening applications
[29,30], the addition of lipid arraying to the portfolio of HEMA
polymer applications emphasizes the use of this solid substrate
as a very attractive platform for a variety of biomedical applica-
tions. The combination of microfluidic settings and phospho-
lipid arrays on solid supports like HEMA polymer may also
prove fruitful for a multitude of sensing applications.
Experimental
Substrate preparation
Fabrication of alkyne HEMA-EDMA polymer film was de-
scribed in our previous work [9,10]. Briefly, a 12.5 µm thin,
hydrophilic porous polymer film was firstly prepared on a glass
substrate by using photoinitiated copolymerization of
2-hydroxyethyl methacrylate and ethylene dimethacrylate in the
presence of porogens (1-decanol and cyclohexanol) [29]. This
procedure leads to the formation of a thin film of a highly cross-
linked and porous (due to the presence of porogens) hydro-
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philic polymethacrylate layer. The porous structure is a perme-
able network of interconnected polymer nanoglobules with
pores of around 150 nm.
Microcontact spotting
The patterning of lipid arrays was performed on a NLP 2000
system (NanoInk, USA) with oxygen plasma activated
(0.2 mbar O2, 2 min) SPT probes (SPT-S-C10S, BioForce
Nanosciences, USA). All lipids were purchased from Avanti
Polar Lipids. Ink mixtures were prepared by admixing various
lipids to DOPC carrier lipid: DOPC (20 mg/mL) and
Rhodamine-PE (1 mg/mL) or Biotin-PE (1 mg/mL) or DNP-
cap-PE (10 mg/mL) were used to prepare a 1 µM total lipid
content ink mixture, sonicated together, air dried to remove the
chloroform solvent and reconstituted with ethanol and glycerol
(87%) in a 7:3 v/v ratio. Glycerol was added to prevent the
premature drying of the ink on the SPT. Probes were filled with
0.5 µL ink, mounted onto the probe holder and used directly for
spotting on unmodified poly(2-hydroxyethyl methacrylate-co-
ethylene dimethacrylate) support (HEMA). Spotting was per-
formed at 55–65% relative humidity. All patterning procedures
were carried out with the sample stage tilted by 8° with respect
to the SPT tip to minimize the probability of a contact between
the ink reservoir and the sample surface. For all patterns, except
the ones used for spot size versus dwell time analysis, a dwell
time of 2 s was used for target patterns and 1 s for optical refer-
ence patterns.
Protein binding
Streptavidin-FITC (Streptavidin, Fluorescein Conjugate) was
purchased from Calbiochem and Streptavidin-Cy3 (recombi-
nant from Streptomyces avidinii, Cy3 labelled) was purchased
from Sigma. Prior to protein binding on biotin lipid arrays, sam-
ples were blocked in 10% BSA (Sigma-Aldrich) solution in
PBS (Gibco) for 20 min at room temperature. After washing
with PBS, 0.5 µg solution of STV-Cy3 in PBS was incubated
for 30 min on the substrate. Samples were typically washed
with 100 µL PBS 3× and imaged under fluorescence micro-
scope (Nikon Instruments Inc.).
ARbiot purification and binding was done as follows: Sf9 [23]
cells were cultured with continuous shaking at 110 rpm at a
density of 109 and a temperature of 27 °C in SF900 II medium
(Invitrogen) supplemented with 5% fetal calf serum (FCS). One
day prior to infection the medium was changed to serum-free
SF900 II medium. Cells were infected with baculovirus stocks
typically at MOIs of 5–7. 72 h post-infection cells were treated
with DHT (10−4 M) for 3 h. The infected SF9 cells were lysed
on ice in lysis buffer (20 mM HEPES pH 7.4, 400 mM NaCl,
1 mM β-mercaptoethanol, 1 mM ZnCl2, 1 mM PMSF, 1 mM
Na2V03, 10 μL protease inhibitor cocktail (Roche Mannheim,
Germany) per mL) with 10−4 M DHT and an equivalent amount
of ethanol in a control purification. The lysates were then
centrifuged for 10 min at 14,000g at 4 °C. Isolation of the
biotin-tagged AR samples was performed on a streptavidin–
mutein-matrix (Roche Mannheim, Germany) according to the
manufacturer's instructions at 4 °C [18]. Freshly purified pro-
tein was quantified for total protein content. The concentration
of the protein was measured at 280 nm by using the specific
program 1 A/cm = 1 mg from the spectrophotometer Nanodrop
Lite (Thermo Scientific) in duplicate and with a solution of
elution buffer (10−4 DHT) as the blank. After blocking the sam-
ple surface with 10% BSA solution in PBS for 30 min at RT,
samples were incubated with 0.5 µg solution of STV or STV-
Cy3 in PBS for 30 min at room temperature. Next, samples
were washed 2× with 100 µL PBS, and a final washing step was
carried out with PBS containing 10−4 DHT. Then, 200 µL of
freshly purified ARbiot (0.45 µg/µL) was loaded onto the sam-
ple. Samples were incubated over night at 4 °C for optimal pro-
tein binding. Samples were then washed 3 times with 100 µL
PBS containing 10−4 M DHT and blocked again with 100 µL
fetal bovine serum for 1 h at RT. Thereafter, samples were
washed again 3 times with 100 µL PBS containing 10−4 M
DHT and incubated with 100 µL primary anti-AR antibody (AR
F39.4.1 from Santa Cruz Biotechnology, INC., sc-52309, 1:200
in PBS containing 10−4 M DHT) for 1–2 h at room temperature.
Next, the samples were washed 3 times with 100 μL PBS con-
taining 10−4 M DHT and incubated for 15 min. with 100 μL of
the secondary antibody (Goat anti-Mouse IgG (H+L) Second-
ary Antibody, Alexa Fluor 488, ThermoFisher, A-11001,
diluted in a ratio of 0.5:400 onto PBS containing 10−4 M DHT).
Finally, the membranes were washed 3 times with PBS
containig 10−4 DHT and imaged under upright fluorescence
microscope (Nikon Instruments Inc.).
Antibody binding
DNP-lipid arrays were blocked with 10% BSA in PBS for
30 min at room temperature. After washing 3 times with PBS,
200 µL of 5 µg/mL of anti-DNP IgE-Alexa 488 antibody in
PBS was applied. After 1 h incubation, samples were washed
3 times in PBS and imaged under fluorescence microscope
(Nikon Instruments Inc.).
Fluorescence microscopy and quantification
of signal
Fluorescence microscopy was carried out on an Eclipse 80i
upright microscope (Nikon Instruments Inc.). Fluorescence
images were taken with 10× or 20× objectives. Images were re-
corded with a CoolSNAP HQ2 camera (Photometrics). Patterns
were aligned for imaging by using alignment markers scratched
onto the polymer surface. The bleaching of fluorophores was
minimized (especially for quantitative measurements) by first
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focusing on the alignment mark before exposing the patterned
area to light, and the lamp intensity was kept at a minimum.
Fluorescence intensity profiles were generated by using NIS-
AR software installed on the microscope PC (Nikon Instru-
ments Inc.). For measurements the patterned areas of interest
were marked, and fluorescence intensity was automatically re-
corded. Mean fluorescence intensity after background extrac-
tion was calculated using the onboard NIS-AR software as pre-
viously described in [17].
Acknowledgements
This work was partly carried out with the support
of the Karlsruhe Nano Micro Facility (KNMF, http://
www.knmf.kit.edu), a Helmholtz Research Infrastructure at
the Karlsruhe Institute of Technology (KIT, http://
www.kit.edu). PL thanks the Helmholtz Association's Initiative
and Networking Fund (grant VH-NG-621).
References
1. Fodor, S. P.; Read, J. L.; Pirrung, M. C.; Stryer, L.; Lu, A. T.; Solas, D.
Science 1991, 251, 767–773. doi:10.1126/science.1990438
2. Barbulovic-Nad, I.; Lucente, M.; Sun, Y.; Zhang, M.; Wheeler, A. R.;
Bussmann, M. Crit. Rev. Biotechnol. 2006, 26, 237–259.
doi:10.1080/07388550600978358
3. Sassolas, A.; Leca-Bouvier, B. D.; Blum, L. J. Chem. Rev. 2008, 108,
109–139. doi:10.1021/cr0684467
4. Weinrich, D.; Jonkheijm, P.; Niemeyer, C. M.; Waldmann, H.
Angew. Chem., Int. Ed. 2009, 48, 7744–7751.
doi:10.1002/anie.200901480
5. Yamada, M.; Imaishi, H.; Morigaki, K. Langmuir 2013, 29, 6404–6408.
doi:10.1021/la400570h
6. Chen, Y.; Clegg, N. J.; Scher, H. I. Lancet Oncol. 2009, 10, 981–991.
doi:10.1016/S1470-2045(09)70229-3
7. Brennan, K. M.; Galban-Horcajo, F.; Rinaldi, S.; O'Leary, C. P.;
Goodyear, C. S.; Kalna, G.; Arthur, A.; Elliot, C.; Barnett, S.;
Linington, C.; Bennett, J. L.; Owens, G. P.; Willison, H. J.
J. Neuroimmunol. 2011, 238, 87–95.
doi:10.1016/j.jneuroim.2011.08.002
8. Kanter, J. L.; Narayana, S.; Ho, P. P.; Catz, I.; Warren, K. G.;
Sobel, R. A.; Steinman, L.; Robinson, W. H. Nat. Med. 2006, 12,
138–143. doi:10.1038/nm1344
9. Hirtz, M.; Lyon, M.; Feng, W.; Holmes, A. E.; Fuchs, H.; Levkin, P. A.
Beilstein J. Nanotechnol. 2013, 4, 377–384. doi:10.3762/bjnano.4.44
10. Hirtz, M.; Feng, W.; Fuchs, H.; Levkin, P. A. Adv. Mater. Interfaces
2016, 3, 1500469. doi:10.1002/admi.201500469
11. Lenhert, S.; Sun, P.; Wang, Y.; Fuchs, H.; Mirkin, C. A. Small 2007, 3,
71–75. doi:10.1002/smll.200600431
12. Urtizberea, A.; Hirtz, M. Nanoscale 2015, 7, 15618–15634.
doi:10.1039/C5NR04352B
13. Xu, J.; Lynch, M.; Huff, J. L.; Mosher, C.; Vengasandra, S.; Ding, G.;
Henderson, E. Biomed. Microdevices 2004, 6, 117–123.
doi:10.1023/B:BMMD.0000031748.13353.10
14. Davydova, M.; de los Santos Pereira, A.; Bruns, M.; Kromka, A.;
Ukraintsev, E.; Hirtz, M.; Rodriguez-Emmenegger, C. RSC Adv. 2016,
6, 57820–57827. doi:10.1039/C6RA12194B
15. Hirtz, M.; Greiner, A. M.; Landmann, T.; Bastmeyer, M.; Fuchs, H.
Adv. Mater. Interfaces 2014, 1, 1300129. doi:10.1002/admi.201300129
16. Helm, C. A.; Knoll, W.; Israelachvili, J. N. Proc. Natl. Acad. Sci. U. S. A.
1991, 88, 8169–8173. doi:10.1073/pnas.88.18.8169
17. Sekula-Neuner, S.; Maier, J.; Oppong, E.; Cato, A. C. B.; Hirtz, M.;
Fuchs, H. Small 2012, 8, 585–591. doi:10.1002/smll.201101694
18. Juzumiene, D.; Chang, C.-y.; Fan, D.; Hartney, T.; Norris, J. D.;
McDonnell, D. P. Nucl. Recept. Signaling 2005, 3, e001.
doi:10.1621/nrs.03001
19. Jin, H.-J.; Kim, J.; Yu, J. Transl. Androl. Urol. 2013, 2, 158–177.
doi:10.3978/j.issn.2223-4683.2013.09.01
20. Ni, M.; Chen, Y.; Lim, E.; Wimberly, H.; Bailey, S. T.; Imai, Y.;
Rimm, D. L.; Liu, X. S.; Brown, M. Cancer Cell 2011, 20, 119–131.
doi:10.1016/j.ccr.2011.05.026
21. Cortes, C. J.; Miranda, H. C.; Frankowski, H.; Batlevi, Y.; Young, J. E.;
Le, A.; Ivanov, N.; Sopher, B. L.; Carromeu, C.; Muotri, A. R.;
Garden, G. A.; La Spada, A. R. Nat. Neurosci. 2014, 17, 1180–1189.
doi:10.1038/nn.3787
22. de Leon, J. T.; Iwai, A.; Feau, C.; Garcia, Y.; Balsiger, H. A.;
Storer, C. L.; Suro, R. M.; Garza, K. M.; Lee, S.; Kim, Y. S.; Chen, Y.;
Ning, Y.-M.; Riggs, D. L.; Fletterick, R. J.; Guy, R. K.; Trepel, J. B.;
Neckers, L. M.; Cox, M. B. Proc. Natl. Acad. Sci. U. S. A. 2011, 108,
11878–11883. doi:10.1073/pnas.1105160108
23. Jochum, T.; Ritz, M. E.; Schuster, C.; Funderburk, S. F.; Jehle, K.;
Schmitz, K.; Brinkmann, F.; Hirtz, M.; Moss, D.; Cato, A. C. B.
Biochim. Biophys. Acta 2012, 1822, 1070–1078.
doi:10.1016/j.bbadis.2012.02.006
24. Sekula, S.; Fuchs, J.; Weg-Remers, S.; Nagel, P.; Schuppler, S.;
Fragala, J.; Theilacker, N.; Franzreb, M.; Wingren, C.; Ellmark, P.;
Borrebaeck, C. A. K.; Mirkin, C. A.; Fuchs, H.; Lenhert, S. Small 2008,
4, 1785–1793. doi:10.1002/smll.200800949
25. Gregory, C. W.; Johnson, R. T.; Mohler, J. L., Jr.; French, F. S.;
Wilson, E. M. Cancer Res. 2001, 61, 2892–2898.
26. Orth, R. N.; Kameoka, J.; Zipfel, W. R.; Ilic, B.; Webb, W. W.;
Clark, T. G.; Craighead, H. G. Biophys. J. 2003, 85, 3066–3073.
doi:10.1016/S0006-3495(03)74725-0
27. Saliba, A.-E.; Vonkova, I.; Deghou, S.; Ceschia, S.; Tischer, C.;
Kugler, K. G.; Bork, P.; Ellenberg, J.; Gavin, A.-C. Nat. Protoc. 2016,
11, 1021–1038. doi:10.1038/nprot.2016.059
28. Efremov, A. N.; Stanganello, E.; Welle, A.; Scholpp, S.; Levkin, P. A.
Biomaterials 2013, 34, 1757–1763.
doi:10.1016/j.biomaterials.2012.11.034
29. Geyer, F. L.; Ueda, E.; Liebel, U.; Grau, N.; Levkin, P. A.
Angew. Chem., Int. Ed. 2011, 50, 8424–8427.
doi:10.1002/anie.201102545
30. Ueda, E.; Geyer, F. L.; Nedashkivska, V.; Levkin, P. A. Lab Chip 2012,
12, 5218–5224. doi:10.1039/c2lc40921f
Beilstein J. Nanotechnol. 2017, 8, 715–722.
722
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of
Nanotechnology terms and conditions:
(http://www.beilstein-journals.org/bjnano)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjnano.8.75
